Nine top stock picks to prepare your portfolio for 2025

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.
Ozempic injection pens move along a conveyor at the Novo Nordisk production facilities in Hillerod, Denmark.Credit:Bloomberg

Nine top stock picks to prepare your portfolio for 2025

January 21, 2025
Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.
Read Transcript

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.

Sharing their investment ideas for those thinking long-term, these Australian and global fund managers are offering a sneak peek into their expectations for the upcoming year.

They’re also generous with their time, investing pro bono on behalf of the Future Generation-listed investment companies (ASX: FGX and FGG) – Australia’s first dual-purpose investment vehicles that deliver both investment and social returns.

By managers waiving their usual management and performance fees, Future Generation donates 1 per cent of its assets each year to youth-focused Australian charities – donating a total of $87 million since inception. Check out their picks below:

Eleanor Swanson, Firetrail Investments

Top stock: Qoria (ASX:QOR)

Eleanor Swanson, Firetrail Investments. Credit: Edwina Pickles

Rationale: Qoria is an ed-tech company tackling one of the most pressing challenges of our digital age: online safety for children. With cyberbullying, inappropriate content, and digital addiction on the rise, Qoria’s suite of products helps schools and families protect kids while navigating the digital world.

Their offerings range from firewalls and content filtering to real-time monitoring of at-risk children and parental control tools, with the company having a global reach – serving over 22 million students across 29,000 schools in more than 100 countries.

Regulatory support is a key driver of Qoria’s growth. For instance, the UK recently mandated that schools adopt monitoring technology to keep students safe, unlocking a potential $10 million annual revenue opportunity through a strategic partnership with Schools Broadband. With similar regulations likely to follow worldwide, Qoria is uniquely positioned to capitalise on this growing demand.

The company operates in a rapidly expanding market valued at $11 billion and doubling every three years. Add to that its strong revenue growth, operational de-risking, and undemanding valuation, and Qoria stands out as a compelling long-term investment in the essential field of digital safety.

Steve Lambeth, Portfolio Manager, Clime

Top stock: Ramsay Healthcare (ASX:RHC)

Rationale: Put simply, we see the two issues of value destruction via offshore investment and earnings headwinds onset by COVID as changing for the better.

On the first issue, RHC has stopped lobbing capital at offshore markets and is open to divestments (subject to price). Given RHC’s share price implies negligible value for Ramsay Sante, the hurdle is low to create value by taking action.

Even a partial sell-down of Ramsay Sante (53 per cent owned by RHC) would bring significant benefits given the current consolidation of Ramsay Sante pollutes the picture of RHC’s true profitability and balance sheet.

If RHC can find a way to further clean up the international operations, any sale proceeds can be returned to shareholders to help unlock the $900 million of franking credits on RHC’s balance sheet.

The second topic of earnings headwinds onset by COVID is, at last, turning the corner after several false starts. RHC has the number one position in the Australian private hospital market and is well-placed to recover lost earnings as struggling peers reduce capacity and as inflation in pricing and costs moves back into balance.

At $40 per share, we think the market is placing too much weight on today’s depressed earnings picture. It also seems forgotten by the market that KKR bid $88 per share for RHC two years ago.

Although the bid didn’t materialise, we believe it recognised the strategic value of RHC’s competitively advantaged Australian hospital network, which is predominantly freehold-owned and well-positioned to meet ongoing demand growth for hospital services in the years ahead.

Jacob Mitchell, Antipodes

Top stock: Didi Global (DIDIY)

Antipodes’ Jacob Mitchell.Credit:Steven Siewert

Rationale: Didi is the leading ride-hailing app in China that has a strong presence in Latin America where it holds around 40 per cent share in key markets like Brazil and Mexico, as well as building a small business in Australia.

Ride-hailing in China has a very long tail of smaller competitors, the bulk of which emerged during Didi’s 18-month suspension, which saw it banned from the local app store and resulted in it being de-listed from the NYSE.

Despite this, Didi has maintained a market share above 70 per cent, and the company has turned profitable while it grew transaction revenue by over 10 per cent against a weak consumer backdrop.

Didi is on track to see margins improve from around 3 per cent to high single digits over the next 5 years, with international operations turning profitable in Latin America over the next 3 years, even while it grows its food delivery business.

Didi trades at ~6x 2026 earnings compared to 14x for Uber and 14x for Grab. We expect the company to list on the HK stock exchange over the next year, and if this is realised, we expect the valuation discount to close quickly.

Armina Rosenberg, Minotaur Corporation

Top stock: COVER Corporation

Armina Rosenberg in 2019. Credit: Louise Kennerley

Rationale: COVER Corporation is a Japanese company at the forefront of digital entertainment through its VTuber talent management business.

The company has demonstrated extraordinary growth, scaling revenue from $1 million to $360 million in just five years.

It offers an innovative blend of talent management, similar to the K-pop industry, and interesting character creation, as you see in the WWE.

Key investment merits include:

  1. Strong revenue diversification beyond streaming (now only 24 per cent of revenue) into concerts (16 per cent), merchandising (46 per cent), and licensing (15 per cent), with revenue per VTuber growing from $400,000 in 2020 to over $4 million today.
  2. Exceptional management under chief executive Motoaki “Yagoo” Tanigo, whose talent-first approach has resulted in industry-leading retention rates and the ability to rapidly grow new talent’s audience bases.
  3. Global expansion potential, with successful moves into Western markets through group launches like HoloJustice, featuring European and American talent.
  4. Attractive valuation at 23x forward P/E with >40 per cent guided net profit growth, which appears conservative.
  5. Strong competitive moat through network effects, brand value, and technological infrastructure that helps VTubers achieve greater success than they could independently.

The stock represents an untapped opportunity to invest in the future of digital entertainment at a reasonable valuation, given its growth profile and market position.

David Allen, Plato

Top stocks: Lockheed Martin, Rolls-Royce, Novo Nordisk, Eli Lilly

Rationale: We believe we are in the midst of a decade-long megatrend of unprecedented defence spending. Geopolitical tensions in regions like the Middle East, Taiwan, and Ukraine, coupled with US strategic ambivalence, have only accelerated this shift.

Within this space, we see significant opportunities in Lockheed Martin, BAE Systems, and Rolls-Royce. Beyond their exposure to rising defence budgets, these companies provide an additional advantage: their defensive nature in portfolios, often performing well during periods of heightened geopolitical instability.

In the healthcare sector, we’ve had strong conviction in Novo Nordisk, the makers of the groundbreaking anti-obesity drug Ozempic. However, we are even more bullish on Eli Lilly. Their drug, Mounjaro, has demonstrated approximately 50 per cent greater efficacy at a lower cost, positioning it as a potential market leader.

These drugs are being hailed as the “Swiss Army knives” of modern medicine, with emerging data showing potential applications for conditions as diverse as heart disease, diabetes, infertility, Alzheimer’s, arthritis, and addiction.

Military spending is forecast to significantly increase in the coming decade. Credit:AP 

Nick Markiewicz, Ellerston

Top stock: Corpay (CPAY-US)

Rationale: In an expensive global equity market, Corpay is an overlooked gem, offering attractive earnings growth at an undemanding valuation.

Corpay is a global payments and software company that helps businesses facilitate transactions over three main verticals: fuel cards (largely for trucking fleets), accounts payables and FX.

The business has been led by the same chief executive for 25 years, over which time he has delivered nearly 20 per cent annual EPS growth, placing him among a small number of elite capital managers.

Today, Corpay has grown to become the largest commercial issuer of Mastercard in North America and the largest non-bank FX dealer in the US.

Despite this success, the business trades at an undemanding forward multiple of just 16x earnings, well below its long-term average of 28x and that of other top payment companies.

Market concerns over the long-term impact of electric vehicles on Corpay’s fuel card business – its largest revenue driver – have weighed on sentiment.

However, these concerns are likely overdone. EV penetration remains low, and the fuel card business continues to generate significant cash flow, while Corpay’s accounts payable and FX segments continue to grow at high double-digit rates, which, we think, are likely to be sustained for many years.

Katie Hudson, Yarra Capital Management

Top stock: Auckland Airport

Katie Hudson, the head of Australian equities research at Yarra Capital Management. Credit:Arsineh Houspian

Rationale: Auckland Airport is a long-term compounder with the ability to grow earnings over time driven by traffic growth, price growth and investment in capital projects with compelling, regulated rates of return. An added bonus is that an environment of falling interest rates is supportive of long-duration assets like airports.

Kieran Moore, Munro Partners

Top stock: Taiwan Semiconductor

Rationale: Taiwan Semiconductor is the world’s largest semiconductor foundry that produces over 60 per cent of the world’s semiconductors that end up in a variety of different companies and sectors.

TSMC has built its reputation as the leading foundry through its scale, ability to deliver semiconductor products and technology leadership. The company produces semiconductors for some of the world’s largest businesses, such as Apple, Nvidia and Broadcom.

At Munro, we believe TSMC sits at the forefront of two long runways of growth. Firstly, the company produces semiconductor content that is critical for AI servers. TSMC expects AI server revenues to grow at a 50 per cent CAGR over the next five years and will represent over one-fifth of their total revenues by 2028. Management has revised this target upwards several times in the last 12 months.

Secondly, as AI progresses over time, we expect TSMC to play a significant role in AI moving to the “edge”, where AI applications are processed on PCs and smartphones, as opposed to exclusively within data centres. Over the next five years, we anticipate TSMC can double its earnings per share.

Zehrid Osmani, Martin Currie. Credit: Brook Mitchell. 

Zehrid Osmani, Martin Currie

Top stock: BE Semiconductor Industries

Rationale: BESI is a Dutch company that is, in our view, well-placed to stretch the so-called “Moore’s law” within the semiconductor industry (the observation by Gordon Moore back in 1975 that the number of transistors in an integrated circuit doubles about every two years).

BESI is solely dedicated to the development and manufacture of cloud data and AI semiconductor assembly equipment for the global semis and electronics industries. Stretching Moore’s law has become a challenge in the semiconductor industry – BESI’s chiplets help achieve just that.

A “chiplet” is part of a processing module that makes up a larger integrated circuit. Rather than manufacturing a processor on a single piece of silicon with the desired number of cores, chiplets allow manufacturers to use multiple smaller chips to make up a larger integrated circuit.

At a high level, by breaking up a larger single chip into smaller chiplets, manufacturers can gain several benefits, notably an improved yield, a more specialised and optimised chip manufacturing process, lower production costs, faster time to market, and a more flexible approach to tailored microchip designs.

Overall, we predict chiplets to become an increasingly prominent secular theme with early adopters, including Intel and AMD. Growth in this area is driven by high demand for high-performance computing for AI, gaming and data centres, alongside advance memory, smartphone processors, and sensor/display functions.

Whilst the semiconductors industry remains cyclical, over a 5-year basis, we predict BESI’s sales and earnings to grow at an annualised rate of well over 20 per cent and its returns on invested capital to increase steadily from an already very high level of 54 per cent.

This article was originally posted by The Age here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian Financial Review, published on 21 Jan 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Health care, ride-sharing, and the emerging world of YouTube entertainers are among the industries leading investors have picked for growth in 2025.

Sharing their investment ideas for those thinking long-term, these Australian and global fund managers are offering a sneak peek into their expectations for the upcoming year.

They’re also generous with their time, investing pro bono on behalf of the Future Generation-listed investment companies (ASX: FGX and FGG) – Australia’s first dual-purpose investment vehicles that deliver both investment and social returns.

By managers waiving their usual management and performance fees, Future Generation donates 1 per cent of its assets each year to youth-focused Australian charities – donating a total of $87 million since inception. Check out their picks below:

Eleanor Swanson, Firetrail Investments

Top stock: Qoria (ASX:QOR)

Eleanor Swanson, Firetrail Investments. Credit: Edwina Pickles

Rationale: Qoria is an ed-tech company tackling one of the most pressing challenges of our digital age: online safety for children. With cyberbullying, inappropriate content, and digital addiction on the rise, Qoria’s suite of products helps schools and families protect kids while navigating the digital world.

Their offerings range from firewalls and content filtering to real-time monitoring of at-risk children and parental control tools, with the company having a global reach – serving over 22 million students across 29,000 schools in more than 100 countries.

Regulatory support is a key driver of Qoria’s growth. For instance, the UK recently mandated that schools adopt monitoring technology to keep students safe, unlocking a potential $10 million annual revenue opportunity through a strategic partnership with Schools Broadband. With similar regulations likely to follow worldwide, Qoria is uniquely positioned to capitalise on this growing demand.

The company operates in a rapidly expanding market valued at $11 billion and doubling every three years. Add to that its strong revenue growth, operational de-risking, and undemanding valuation, and Qoria stands out as a compelling long-term investment in the essential field of digital safety.

Steve Lambeth, Portfolio Manager, Clime

Top stock: Ramsay Healthcare (ASX:RHC)

Rationale: Put simply, we see the two issues of value destruction via offshore investment and earnings headwinds onset by COVID as changing for the better.

On the first issue, RHC has stopped lobbing capital at offshore markets and is open to divestments (subject to price). Given RHC’s share price implies negligible value for Ramsay Sante, the hurdle is low to create value by taking action.

Even a partial sell-down of Ramsay Sante (53 per cent owned by RHC) would bring significant benefits given the current consolidation of Ramsay Sante pollutes the picture of RHC’s true profitability and balance sheet.

If RHC can find a way to further clean up the international operations, any sale proceeds can be returned to shareholders to help unlock the $900 million of franking credits on RHC’s balance sheet.

The second topic of earnings headwinds onset by COVID is, at last, turning the corner after several false starts. RHC has the number one position in the Australian private hospital market and is well-placed to recover lost earnings as struggling peers reduce capacity and as inflation in pricing and costs moves back into balance.

At $40 per share, we think the market is placing too much weight on today’s depressed earnings picture. It also seems forgotten by the market that KKR bid $88 per share for RHC two years ago.

Although the bid didn’t materialise, we believe it recognised the strategic value of RHC’s competitively advantaged Australian hospital network, which is predominantly freehold-owned and well-positioned to meet ongoing demand growth for hospital services in the years ahead.

Jacob Mitchell, Antipodes

Top stock: Didi Global (DIDIY)

Antipodes’ Jacob Mitchell.Credit:Steven Siewert

Rationale: Didi is the leading ride-hailing app in China that has a strong presence in Latin America where it holds around 40 per cent share in key markets like Brazil and Mexico, as well as building a small business in Australia.

Ride-hailing in China has a very long tail of smaller competitors, the bulk of which emerged during Didi’s 18-month suspension, which saw it banned from the local app store and resulted in it being de-listed from the NYSE.

Despite this, Didi has maintained a market share above 70 per cent, and the company has turned profitable while it grew transaction revenue by over 10 per cent against a weak consumer backdrop.

Didi is on track to see margins improve from around 3 per cent to high single digits over the next 5 years, with international operations turning profitable in Latin America over the next 3 years, even while it grows its food delivery business.

Didi trades at ~6x 2026 earnings compared to 14x for Uber and 14x for Grab. We expect the company to list on the HK stock exchange over the next year, and if this is realised, we expect the valuation discount to close quickly.

Armina Rosenberg, Minotaur Corporation

Top stock: COVER Corporation

Armina Rosenberg in 2019. Credit: Louise Kennerley

Rationale: COVER Corporation is a Japanese company at the forefront of digital entertainment through its VTuber talent management business.

The company has demonstrated extraordinary growth, scaling revenue from $1 million to $360 million in just five years.

It offers an innovative blend of talent management, similar to the K-pop industry, and interesting character creation, as you see in the WWE.

Key investment merits include:

  1. Strong revenue diversification beyond streaming (now only 24 per cent of revenue) into concerts (16 per cent), merchandising (46 per cent), and licensing (15 per cent), with revenue per VTuber growing from $400,000 in 2020 to over $4 million today.
  2. Exceptional management under chief executive Motoaki “Yagoo” Tanigo, whose talent-first approach has resulted in industry-leading retention rates and the ability to rapidly grow new talent’s audience bases.
  3. Global expansion potential, with successful moves into Western markets through group launches like HoloJustice, featuring European and American talent.
  4. Attractive valuation at 23x forward P/E with >40 per cent guided net profit growth, which appears conservative.
  5. Strong competitive moat through network effects, brand value, and technological infrastructure that helps VTubers achieve greater success than they could independently.

The stock represents an untapped opportunity to invest in the future of digital entertainment at a reasonable valuation, given its growth profile and market position.

David Allen, Plato

Top stocks: Lockheed Martin, Rolls-Royce, Novo Nordisk, Eli Lilly

Rationale: We believe we are in the midst of a decade-long megatrend of unprecedented defence spending. Geopolitical tensions in regions like the Middle East, Taiwan, and Ukraine, coupled with US strategic ambivalence, have only accelerated this shift.

Within this space, we see significant opportunities in Lockheed Martin, BAE Systems, and Rolls-Royce. Beyond their exposure to rising defence budgets, these companies provide an additional advantage: their defensive nature in portfolios, often performing well during periods of heightened geopolitical instability.

In the healthcare sector, we’ve had strong conviction in Novo Nordisk, the makers of the groundbreaking anti-obesity drug Ozempic. However, we are even more bullish on Eli Lilly. Their drug, Mounjaro, has demonstrated approximately 50 per cent greater efficacy at a lower cost, positioning it as a potential market leader.

These drugs are being hailed as the “Swiss Army knives” of modern medicine, with emerging data showing potential applications for conditions as diverse as heart disease, diabetes, infertility, Alzheimer’s, arthritis, and addiction.

Military spending is forecast to significantly increase in the coming decade. Credit:AP 

Nick Markiewicz, Ellerston

Top stock: Corpay (CPAY-US)

Rationale: In an expensive global equity market, Corpay is an overlooked gem, offering attractive earnings growth at an undemanding valuation.

Corpay is a global payments and software company that helps businesses facilitate transactions over three main verticals: fuel cards (largely for trucking fleets), accounts payables and FX.

The business has been led by the same chief executive for 25 years, over which time he has delivered nearly 20 per cent annual EPS growth, placing him among a small number of elite capital managers.

Today, Corpay has grown to become the largest commercial issuer of Mastercard in North America and the largest non-bank FX dealer in the US.

Despite this success, the business trades at an undemanding forward multiple of just 16x earnings, well below its long-term average of 28x and that of other top payment companies.

Market concerns over the long-term impact of electric vehicles on Corpay’s fuel card business – its largest revenue driver – have weighed on sentiment.

However, these concerns are likely overdone. EV penetration remains low, and the fuel card business continues to generate significant cash flow, while Corpay’s accounts payable and FX segments continue to grow at high double-digit rates, which, we think, are likely to be sustained for many years.

Katie Hudson, Yarra Capital Management

Top stock: Auckland Airport

Katie Hudson, the head of Australian equities research at Yarra Capital Management. Credit:Arsineh Houspian

Rationale: Auckland Airport is a long-term compounder with the ability to grow earnings over time driven by traffic growth, price growth and investment in capital projects with compelling, regulated rates of return. An added bonus is that an environment of falling interest rates is supportive of long-duration assets like airports.

Kieran Moore, Munro Partners

Top stock: Taiwan Semiconductor

Rationale: Taiwan Semiconductor is the world’s largest semiconductor foundry that produces over 60 per cent of the world’s semiconductors that end up in a variety of different companies and sectors.

TSMC has built its reputation as the leading foundry through its scale, ability to deliver semiconductor products and technology leadership. The company produces semiconductors for some of the world’s largest businesses, such as Apple, Nvidia and Broadcom.

At Munro, we believe TSMC sits at the forefront of two long runways of growth. Firstly, the company produces semiconductor content that is critical for AI servers. TSMC expects AI server revenues to grow at a 50 per cent CAGR over the next five years and will represent over one-fifth of their total revenues by 2028. Management has revised this target upwards several times in the last 12 months.

Secondly, as AI progresses over time, we expect TSMC to play a significant role in AI moving to the “edge”, where AI applications are processed on PCs and smartphones, as opposed to exclusively within data centres. Over the next five years, we anticipate TSMC can double its earnings per share.

Zehrid Osmani, Martin Currie. Credit: Brook Mitchell. 

Zehrid Osmani, Martin Currie

Top stock: BE Semiconductor Industries

Rationale: BESI is a Dutch company that is, in our view, well-placed to stretch the so-called “Moore’s law” within the semiconductor industry (the observation by Gordon Moore back in 1975 that the number of transistors in an integrated circuit doubles about every two years).

BESI is solely dedicated to the development and manufacture of cloud data and AI semiconductor assembly equipment for the global semis and electronics industries. Stretching Moore’s law has become a challenge in the semiconductor industry – BESI’s chiplets help achieve just that.

A “chiplet” is part of a processing module that makes up a larger integrated circuit. Rather than manufacturing a processor on a single piece of silicon with the desired number of cores, chiplets allow manufacturers to use multiple smaller chips to make up a larger integrated circuit.

At a high level, by breaking up a larger single chip into smaller chiplets, manufacturers can gain several benefits, notably an improved yield, a more specialised and optimised chip manufacturing process, lower production costs, faster time to market, and a more flexible approach to tailored microchip designs.

Overall, we predict chiplets to become an increasingly prominent secular theme with early adopters, including Intel and AMD. Growth in this area is driven by high demand for high-performance computing for AI, gaming and data centres, alongside advance memory, smartphone processors, and sensor/display functions.

Whilst the semiconductors industry remains cyclical, over a 5-year basis, we predict BESI’s sales and earnings to grow at an annualised rate of well over 20 per cent and its returns on invested capital to increase steadily from an already very high level of 54 per cent.

This article was originally posted by The Age here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian Financial Review, published on 21 Jan 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by The Age, published on Jan 21, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.